Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10075826 | 0.88 | L3MBTL1 (0.39) | MAPTRAB9APARP10ALDH1A1KMT2A | |
| SCHEMBL10075825 | 0.85 | KMT2A (0.51) | MAPTALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL10075760 | 0.84 | L3MBTL1 (0.44) | MAPTRAB9AALDH1A1NPC1KMT2A | |
| SCHEMBL10075808 | 0.84 | L3MBTL1 (0.41) | ALDH1A1KMT2AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL10075709 | 0.84 | L3MBTL1 (0.43) | MAPTRAB9AALDH1A1NPC1KMT2A | |
| SCHEMBL31098997 | 0.83 | POLB (0.48) | MAPTRAB9APARP10ALDH1A1KMT2A | |
| SCHEMBL10075753 | 0.82 | L3MBTL1 (0.43) | MAPTRAB9AALDH1A1NPC1KMT2A | |
| SCHEMBL10075804 | 0.82 | L3MBTL1 (0.43) | MAPTRAB9AALDH1A1NPC1KMT2A | |
| SCHEMBL19795435 | 0.82 | HPGD (0.56) | MAPTRAB9AALDH1A1NPC1KMT2A | |
| SCHEMBL16019156 | 0.82 | HPGD (0.56) | MAPTRAB9AALDH1A1NPC1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586827-B1 | CURABLE RESIN COMPOSITION | ADEKA CORP (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-8735511-B2 | Curing resin composition | ADEKA CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8735511-B2 | Curing resin composition | ADEKA CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| EP-2586827-A1 | CURABLE RESIN COMPOSITION | Adeka Corporation (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-20120115972-A1 | CURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120115972-A1 | CURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2012-05-10 | — | — | US | disclosed |
| US-8148045-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8148045-B2 | Oxime ester compound and photopolymerization initiator containing the same | ADEKA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2327689-A1 | Oxime ester compound and photopolymerization initiator containing the same | Adeka Corporation (JP) | 2011-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110129778-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME | OXER1, OR10J3, CDK11B | MAPT 3494/4885RAB9A 3932/4885PARP10 495/4885 |
| US-20120115972-A1 | CURING RESIN COMPOSITION | LTA, LOXL1, PLOD2 | MAPT 154/4885RAB9A 3603/4885PARP10 3515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.